Amneal Pharmaceuticals (AMRX) Prepaid Assets (2017 - 2026)

Amneal Pharmaceuticals' Prepaid Assets history runs 10 years deep, the most recent figure standing at $103.1 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 16.46% year-over-year to $103.1 million in Q1 2026; TTM through Mar 2026 was $103.1 million, a 16.46% increase from a year earlier, with the FY2025 full-year figure at $98.4 million, up 21.9% from the prior year.
• Prepaid Assets climbed to $103.1 million in Q1 2026 per AMRX's latest filing, from $98.4 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $232.2 million in Q2 2022 and bottomed at $80.7 million in Q4 2024.
• The 5-year median for Prepaid Assets is $88.5 million (2025), against an average of $103.1 million.
• Across the five-year window, Prepaid Assets soared 123.71% in 2022 and slumped 64.79% in 2023, its largest moves.
• Year by year, Prepaid Assets stood at $103.6 million in 2022, then fell by 20.16% to $82.7 million in 2023, then retreated by 2.38% to $80.7 million in 2024, then advanced by 21.9% to $98.4 million in 2025, then climbed by 4.77% to $103.1 million in 2026.
• Per Business Quant, the three latest AMRX Prepaid Assets figures stand at $103.1 million (Q1 2026), $98.4 million (Q4 2025), and $101.5 million (Q3 2025).